Carbamazepine
- Product NDC
- 17856-0407
- 11-digit product format
- 178560407
- Labeler code
- 17856
- Product ID
- 17856-0407_4948162b-2ed6-4936-9472-e843075a5580
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- carbamazepine
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- ATLANTIC BIOLOGICALS CORP.
- Application
- NDA020712
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2011-12-15
- Marketing end
- 0000-00-00
- Substance
- CARBAMAZEPINE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 17856-0407 | CARBAMAZEPINE CAPSULE, EXTENDED RELEASE [ATLANTIC BIOLOGICALS CORP.] | 3 | Legacy NDC | 20250402_572ef850-a13c-436a-8a29-5afd4cf737c7.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 17856-0407-1 | 17856040701 | 100 POUCH in 1 BOX, UNIT-DOSE (17856-0407-1) > 1 CAPSULE, EXTENDED RELEASE in 1 POUCH | 100 pouch | 2020-01-31 | 0000-00-00 | No | No | Current |